What we do
-
Partner with our pet owners and referring veterinarians to preserve the human-animal bond.
-
Provide superior veterinary clinical trial services by maintaining the gold standard in the veterinary clinical trials arena.
-
Educate pet owners, veterinarians, researchers and physicians about the roles they play in keeping pets happy and healthy.
-
Foster academic and community growth to ensure our clinical trials lead in the practice of safe, innovative, efficient and beneficial veterinary care.
Our Services
- Veterinary Anesthesia
- Image-Guided Tissue Biopsy
- Radiosynoviorthesis
- Computed tomography (CT scan)
- Cone-beam CT
- CT angiography (CTA)
- Radiation Therapy (Yttrium-90/Y-90)
- Fluoroscopy
- Liver scan
- Lung scan
- Magnetic resonance angiography (MRA)
- Magnetic resonance imaging (MRI--1.5T and 3T)
- Myelogram
- Positron emission tomography (PET scan) and PET/CT
- Spiral CT
- SPECT-CT
- Transarterial Embolization and Chemoembolization
- Whole-body cancer scan
Clinical Trials
Canine Cancer Clinical Trial
This clinical trial will enroll a total of 5-7 dogs in order to confirm that 18F DCFPyl PET-CT offers an improved sensitivity for the early detection of hemangiosarcoma cancer or metastatic prostate cancer.
Canine Metastatic Cancer Clinical Trial
This clinical trial will enroll 5-10 dogs to evaluate the efficacy of a novel chemotherapeutic agent called IF7-SN38. This trial includes dogs with metastatic disease. This chemotherapy is delivered intravenously as a series, every other day for three to five days.
Canine Brain Cancer Clinical Trial
This clinical trial will enroll 5-10 dogs to evaluate the efficacy of a novel chemotherapeutic agent called IF7-SN38. This chemotherapy is delivered intravenously as a series, every other day for three to five days.
Coming Soon
- Canine Prostate Cancer
Contact Information
720 Rutland Ave.
Ross Building #315
Baltimore, Maryland 21205
Telephone: 410-614-0105
Email: [email protected]